Vertex Pharmaceuticals Inc.

VRTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009 FY2008 FY2007
Assets
Cash & Equivalents $446.7M $389.1M $355.7M
Accounts Receivable $9.6M
Inventory
Total Current Assets $1.31B
Property, Plant & Equipment $62.3M
Goodwill $26.1M
Intangible Assets (Excl. Goodwill)
Total Assets $1.96B
Liabilities
Accounts Payable $37.0M
Total Current Liabilities $284.9M
Long-Term Debt
Total Liabilities $859.1M
Stockholders' Equity
Retained Earnings $-2.69B
Total Stockholders' Equity $1.10B $238.9M $271.3M
← Newer Page 3 of 3 Older →